Patents Assigned to Guangdong Newopp Biopharmaceuticals Co., Ltd.
  • Heterocyclic compounds as arginase inhibitors
    Patent number: 11655260
    Abstract: Heterocyclic compounds are provided as arginase inhibitors, in particular to a compound represented by Formula (I), or a pharmaceutically acceptable salt, stereoisomer or tautomer, or prodrug thereof and a pharmaceutical composition including the compound.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: May 23, 2023
    Assignee: GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD.
    Inventors: Zhaoyin Wang, Nanxin Li, Jianbin Ma, Yanqiang Shao
  • ALKYLBORONIC ACIDS AS ARGINASE INHIBITORS
    Publication number: 20220251116
    Abstract: Alkylboronic acids are provided as arginase inhibitors represented by Formula (I), or a pharmaceutically acceptable salt, stereoisomer, tautomer, or prodrug thereof and a pharmaceutical composition including compounds.
    Type: Application
    Filed: February 5, 2020
    Publication date: August 11, 2022
    Applicant: Guangdong Newopp Biopharmaceuticals Co., Ltd.
    Inventors: Zhaoyin Wang, Jianbin Ma, Yanqiang Shao, Nanxin Li
  • HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12C
    Publication number: 20220153741
    Abstract: Heterocyclic compounds or pharmaceutically acceptable salt thereof are provided as inhibitors of the KRAS G12C mutant, and compositions containing these compounds which may be used to treat various disease conditions associated with KRAS G12C, such as cancers.
    Type: Application
    Filed: December 20, 2021
    Publication date: May 19, 2022
    Applicant: Guangdong Newopp Biopharmaceuticals Co., Ltd.
    Inventors: Zhaoyin Wang, Nanxin Li
  • HETEROCYCLIC COMPOUNDS AS ARGINASE INHIBITORS
    Publication number: 20200325161
    Abstract: Heterocyclic compounds are provided as arginase inhibitors, in particular to a compound represented by Formula (I), or a pharmaceutically acceptable salt, stereoisomer or tautomer, or prodrug thereof and a pharmaceutical composition including the compound.
    Type: Application
    Filed: December 21, 2018
    Publication date: October 15, 2020
    Applicant: Guangdong Newopp Biopharmaceuticals Co., Ltd.
    Inventors: Zhaoyin Wang, Nanxin Li, Jianbin Ma, Yanqiang Shao